HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jürgen Burhenne Selected Research

Cytochrome P-450 CYP3A Inhibitors

1/2021Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat.
8/2006Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jürgen Burhenne Research Topics

Disease

13Neoplasms (Cancer)
03/2022 - 05/2011
9Malaria
06/2014 - 12/2004
6Multiple Myeloma
06/2021 - 06/2014
5Body Weight (Weight, Body)
01/2020 - 12/2004
5Pulmonary Arterial Hypertension
09/2017 - 01/2013
4Tuberculosis (Tuberculoses)
01/2020 - 08/2016
3Coinfection
01/2021 - 08/2016
3Brain Neoplasms (Brain Tumor)
08/2019 - 05/2012
3Infections
09/2017 - 09/2006
3Critical Illness (Critically Ill)
09/2017 - 09/2006
3Falciparum Malaria (Plasmodium falciparum Malaria)
06/2010 - 01/2005
2Ischemic Stroke
01/2022 - 01/2019
2Stroke (Strokes)
01/2022 - 01/2019
2Glioblastoma (Glioblastoma Multiforme)
12/2021 - 10/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 09/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2020
2Atrial Fibrillation
01/2019 - 01/2018
2Renal Insufficiency (Renal Failure)
09/2017 - 09/2006
2Sarcoma (Soft Tissue Sarcoma)
08/2017 - 01/2016
2Erectile Dysfunction
01/2016 - 12/2005
2Aspergillosis
09/2008 - 09/2006
2Drug-Related Side Effects and Adverse Reactions
08/2006 - 03/2004
1Breast Neoplasms (Breast Cancer)
02/2022
1Neuroblastoma
01/2022
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2022
1Ependymoma
09/2021
1Hepatitis D
09/2021
1Hepatitis B
09/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2021
1Acromegaly
02/2021
1Pituitary ACTH Hypersecretion
02/2021
1Acute Promyelocytic Leukemia
01/2021
1Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
07/2020

Drug/Important Bio-Agent (IBA)

16Pharmaceutical PreparationsIBA
03/2022 - 01/2005
10Voriconazole (Vfend)FDA LinkGeneric
09/2017 - 08/2006
8Methylene Blue (Methylthioninium Chloride)FDA Link
06/2010 - 12/2004
6efavirenz (Sustiva)FDA Link
01/2021 - 01/2011
6Sildenafil Citrate (Viagra)FDA Link
01/2017 - 12/2005
5Cytochrome P-450 CYP3AIBA
02/2022 - 03/2005
5Rifampin (Rifampicin)FDA LinkGeneric
01/2021 - 09/2007
5VorinostatFDA Link
12/2019 - 08/2014
5Phosphodiesterase 5 InhibitorsIBA
09/2017 - 01/2013
4Proteins (Proteins, Gene)FDA Link
02/2022 - 03/2008
4Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 05/2011
4Bortezomib (Velcade)FDA Link
01/2019 - 06/2014
4Tadalafil (Cialis)FDA Link
01/2017 - 01/2013
4Antimalarials (Antimalarial Agents)IBA
06/2014 - 03/2008
4Chloroquine (Aralen)FDA LinkGeneric
10/2006 - 12/2004
3AnticoagulantsIBA
01/2022 - 01/2018
3EnzymesIBA
01/2020 - 03/2005
3Endothelin Receptor AntagonistsIBA
09/2017 - 12/2015
3ambrisentanFDA Link
01/2017 - 01/2013
3Bosentan (Tracleer)FDA Link
01/2017 - 01/2013
3RetinoidsIBA
10/2015 - 05/2011
3Drug CombinationsIBA
10/2006 - 01/2005
2Cytochrome P-450 CYP2C19IBA
02/2022 - 08/2006
2Peptides (Polypeptides)IBA
02/2022 - 02/2021
2SodiumIBA
09/2021 - 09/2006
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2021 - 10/2014
2Cytochrome P-450 CYP3A InhibitorsIBA
01/2021 - 08/2006
2ceritinibIBA
03/2020 - 08/2019
2Midazolam (Versed)FDA LinkGeneric
01/2020 - 01/2014
2Histone Deacetylase InhibitorsIBA
12/2019 - 08/2014
2Melphalan (Alkeran)FDA LinkGeneric
01/2019 - 10/2014
2Cytochrome P-450 CYP2B6 (CYP2B6)IBA
11/2018 - 01/2017
2Histone Deacetylases (Histone Deacetylase)IBA
08/2017 - 08/2014
2CholesterolIBA
08/2016 - 03/2013
2Vitamin A (Retinol)FDA LinkGeneric
10/2015 - 05/2012
2Proteasome InhibitorsIBA
02/2015 - 06/2014
2LipidsIBA
03/2013 - 05/2012
2betadex (beta-cyclodextrin)IBA
07/2010 - 09/2006
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2005 - 03/2005
1Large Neutral Amino Acid-Transporter 1IBA
03/2022
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
03/2022
1AnionsIBA
02/2022
1Ketoconazole (Nizoral)FDA LinkGeneric
02/2022
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
02/2022
1Cystine (L-Cystine)IBA
01/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1Chlormethiazole (Clomethiazole)IBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
12/2021
1Dactinomycin (Actinomycin)FDA LinkGeneric
09/2021
1SymportersIBA
09/2021
1Bile Acids and Salts (Bile Acids)IBA
09/2021
1bulevirtideIBA
09/2021
1selinexorIBA
06/2021
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2021
1pasireotideIBA
02/2021
1CobicistatIBA
01/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1CrizotinibIBA
01/2021
1bremelanotideIBA
07/2020
1osimertinibIBA
07/2020

Therapy/Procedure

21Therapeutics
01/2021 - 03/2004
2Highly Active Antiretroviral Therapy (HAART)
01/2020 - 08/2016
2Drug Therapy (Chemotherapy)
01/2016 - 10/2014
2Renal Replacement Therapy (Therapies, Renal Replacement)
06/2010 - 09/2006
1Radiotherapy
12/2021